1-4 of 4
Feng Hua
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Randomized, Open-Label, Multicenter, Phase 3 Study of High-Dose Vitamin C Plus FOLFOX ± Bevacizumab versus FOLFOX ± Bevacizumab in Unresectable Untreated Metastatic Colorectal Cancer (VITALITY Study)

Feng Wang, Ming-Ming He, Jian Xiao, Yan-Qiao Zhang, Xiang-Lin Yuan, Wei-Jia Fang, Yan Zhang, Wei Wang, Xiao-Hua Hu, Zhi-Gang Ma, Yi-Chen Yao, Zhi-Xiang Zhuang, Fu-Xiang Zhou, Jie-Er Ying, Ying Yuan, Qing-Feng Zou, Zeng-Qing Guo, Xiang-Yuan Wu, Ying Jin, Zong-Jiong Mai, Zhi-Qiang Wang, Hong Qiu, Ying Guo, Si-Mei Shi, Shuang-Zhen Chen, Hui-Yan Luo, Dong-Sheng Zhang, Feng-Hua Wang, Yu-Hong Li, Rui-Hua Xu
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (19): 4232–4239.
https://doi.org/10.1158/1078-0432.CCR-22-0655
Published: 03 October 2022
View article titled, A Randomized, Open-Label, Multicenter, Phase 3 Study of High-Dose Vitamin C Plus FOLFOX ± Bevacizumab versus FOLFOX ± Bevacizumab in Unresectable Untreated Metastatic Colorectal Cancer (VITALITY Study)
Open the PDF for A Randomized, Open-Label, Multicenter, Phase 3 Study of High-Dose Vitamin C Plus FOLFOX ± Bevacizumab versus FOLFOX ± Bevacizumab in Unresectable Untreated Metastatic Colorectal Cancer (VITALITY Study) in another window
Includes: Supplementary data
Journal Articles

Pyrotinib in Patients with HER2-Amplified Advanced Non–Small Cell Lung Cancer: A Prospective, Multicenter, Single-Arm Trial

Zhengbo Song, Dongqing Lv, Shi-Qing Chen, Jianjin Huang, Yuping Li, Shenpeng Ying, Xiaoyu Wu, Feng Hua, Wenxian Wang, Chunwei Xu, Ting Bei, Chan Gao, Zhijian Sun, Yiping Zhang, Shun Lu
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (3): 461–467.
https://doi.org/10.1158/1078-0432.CCR-21-2936
Published: 01 February 2022
View article titled, Pyrotinib in Patients with HER2-Amplified Advanced Non–Small Cell Lung Cancer: A Prospective, Multicenter, Single-Arm Trial
Open the PDF for Pyrotinib in Patients with HER2-Amplified Advanced Non–Small Cell Lung Cancer: A Prospective, Multicenter, Single-Arm Trial in another window
Includes: Supplementary data
Journal Articles

EGFR Fluorescence In situ Hybridization Pattern of Chromosome 7 Disomy Predicts Resistance to Cetuximab in KRAS Wild-type Metastatic Colorectal Cancer Patients

Yu-Hong Li, Fang Wang, Lin Shen, Yan-Ming Deng, Qiong Shao, Fen Feng, Xin An, Feng-Hua Wang, Zhi-Qiang Wang, Rui-Hua Xu, Jian-Yong Shao
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (2): 382–390.
https://doi.org/10.1158/1078-0432.CCR-10-0208
Published: 16 January 2011
View article titled, <em>EGFR</em> Fluorescence <em>In situ</em> Hybridization Pattern of Chromosome 7 Disomy Predicts Resistance to Cetuximab in KRAS Wild-type Metastatic Colorectal Cancer Patients
Open the PDF for <em>EGFR</em> Fluorescence <em>In situ</em> Hybridization Pattern of Chromosome 7 Disomy Predicts Resistance to Cetuximab in KRAS Wild-type Metastatic Colorectal Cancer Patients in another window
Includes: Supplementary data
Journal Articles

Soluble PD-1 Facilitates 4-1BBL–Triggered Antitumor Immunity against Murine H22 Hepatocarcinoma In vivo

Han Xiao, Bo Huang, Ye Yuan, Dong Li, Ling-Fei Han, Yi Liu, Wei Gong, Feng-Hua Wu, Gui-Mei Zhang, Zuo-Hua Feng
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (6): 1823–1830.
https://doi.org/10.1158/1078-0432.CCR-06-2154
Published: 15 March 2007
View article titled, Soluble PD-1 Facilitates 4-1BBL–Triggered Antitumor Immunity against Murine H22 Hepatocarcinoma <em>In vivo</em>
Open the PDF for Soluble PD-1 Facilitates 4-1BBL–Triggered Antitumor Immunity against Murine H22 Hepatocarcinoma <em>In vivo</em> in another window